Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(NASDAQ:EXAS) dropped 46 percent and closed at $9.98, compared to the previous day's close of $18.53. The company plummeted after an unanticipated guideline from United States Preventative Services Task Force (USPSTF) that identified Cologuard, the company's colorectal cancer diagnostic product, as an "alternative" screening method, while leaving the product out of a group of recommended tests.
Talking about the guideline, Ro said, "We previously anticipated an A or B rating for Cologuard, which would have paved a clear path for full reimbursement coverage from private insurance companies." He added, "However, USPSTF did not offer a rating for Cologuard and instead categorized it as one of two ‘alternative' screening strategies. We now enter a 30-day public comment period and anticipate more clarity in the months thereafter."
So sorry I haven't followed to closely here. Exactly what caused the stock to tumble.
looking good so far
I just stated exactly the same in a private platform some minutes ago. Seems a really hard fight to break 8,20 - but "some day" it´s going to happen ;)
Enjoy your day, added a person mark
would be nice to see a close today above 8,20 $$$$$$
I see a good chance here. Higher bottoms step by step
I agree
Some kind of bottom at 7,80
Chance or risk....
Re: wagner Post# 410
There certainly are opaque reasons for plummet from 28 to under 8... The test accuracy rate seems a good alternative to invasive tests for those not in high risk population. Competitors and vested interests in the status quo of highly invasive tests may have been factor in "alternative" versus "recommended" decision by the review agency. But seems like big financial players were all ready to prey on that outcome as cover to push prices down hugely "overnight"
-- apparently in part to take advantage of very low probability options contracts, which also instantly proliferated "overnight" for months into the future.
This is an important medical test option -- I hope the company recovers. And the share price back above 10-14.
There certainly are opaque reasons for plummet from 28 to under 8... The test accuracy rate seems a good alternative to invasive tests for those not in high risk population. Competitors and vested interests in the status quo of highly invasive tests may have been factor in "alternative" versus "recommended" decision by the review agency. But seems like big financial players were all ready to prey on that outcome as cover to push prices down hugely "overnight"
Mayer take over taget by other...
Shorting would be helpful until the offer comes out
Deal was paid 8 $
8 mio shares, Must be idiots .....or
Big Boys in the jungle...
Added some 7,5s
A bid suprised to see lots of weak hands here this morning, a good chance to add shares under 8...
Jep - lots of strength eod. Last trade a 50k share buy
And running.......to the end!
2 green shares today, one of them exas
Here :)
Nice - looks like it needs a company update similar to your link for a real nice move upwards
knock knock
anyone here??? :()
http://www.bizjournals.com/milwaukee/news/2015/10/19/exact-sciences-could-benefit-from-newcancer.html?ana=yahoo
Seen that. Seconds after 4pm. Usually AH trades have zero influence. Maybe a deal
Yes analysts often get it wrong, and change their ratings after the fact, way too late
Actually $64 million exchanged hands near day highs in first few min after hours...
Maybe it's not the best idea to listen to analysts - mostly unreal and misleading when someone tells you a stock gonna make 100% or more short to midterm. Nice day today although some took profits eow
One trade for over $33,000,000 near high of day in after hours.... Hmmm
There is often big incentive to get above 10 if possible to maintain institutional investment, (and power of leverage) and 10 therefore also seems to be a "magic number" triggering dumping on the way down. Here's hoping they recover -- the news reaction seemed way overdone...
Or are all the analysts wrong all the time? ??
Estimate. I'm not a pro trader. Experienced in trading Nasdaq biotechs with huge pps decline. Most make 20-30% if you read them right and buy near the bottom
Is 10 your estimate or recent analyst revision? Just curious...
Jep, already stated at least 10. Maybe Q3 figures on 10/29 are better than expected :) and always a short position to be covered after such a crash
Jep, already stated at least 10. Maybe Q3 figures on 10/29 are better than expected :) and always a short position to be covered after such a crash
IMHO expect 11 again. This dive looked like options contracts related manipulation, coordinated with ambiguous news as a cover.
Same here. 100% in biotech right now
Yes…glad I didn't panic.
The rest of my bios are up today too.
Nice close - near hod. Looks like EXAS ready for reversal.
Same here….added a few under 7
Good day otherwise.
May have settled today and close slightly green. Patience pays imo - gonna see a nice reversal. Added again today
Volume is well above normal. Market is on an upswing, yet EXAS is down.
It has been a week since the rating killed the stock. Somebody big wants out at any price.
Major $$ being made via Options mischiefs. Driven to 7 or lower by those who profit from the Options contracts -- the lower probability the more lucrative in their schemes.
Fear ain´t a good friend in the stock market. Makes no sense to sell on loy. I took the chance, hope selling is done soon. Gonna look at the short report later. Quite sure that short position increased again
This one really being shook this morning. My other bios are mostly up. Trying a few more shares here not even holding a 1/4 of a normal position for me.
A good opportunity today - but not sure if this is the intraday bottom already. Funds ready...
Or maybe earlier. But this stock hasn't seen a bounce so far - maybe bouncing off of the (double)confirmed bottom 8,50. If it dips deeper today I gonna add again. Extremely oversold
You predict 10 again before January?
I love Bio´s - because they are very volatile, esp. after big dips. Still positive for 9,50-10$ here.
GLTY, added a person mark
Yes…prepared tp add a few more at or near double bottom. Only doing this because i was able to exit my own dumb trading here last week without a loss!
Not a large position…..bios not healthy
Looks like 7,50 possible again...
Trying a few more shares here at 7.96
Comments on CCA’s PR: #msg-117638954.
Indeed interesting that several smart people follow a similar strategy gaining on extremely oversold Nasdaq biotechs. Works very well for me, pinks are pure lotto, these biotechs are 'readable' for 20-30%, sometimes more :)
Followers
|
60
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
637
|
Created
|
10/19/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |